Search
for
Sort by
Research 61–90 of 68
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- IGF1- and BM-MSC-incorporating collagen-chitosan scaffolds promote wound healing and hair follicle regeneration.
- Synthesis and Evaluation of Finasteride-Loaded HPMC-Based Nanogels for Transdermal Delivery: A Versatile Nanoscopic Platform
- Effect of injectable calcium alginate-amelogenin hydrogel on macrophage polarization and promotion of jaw bone osteogenesis
- Alopecia areata universalis nach Sitagliptin-Einnahme
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Inhibiting dipeptidyl peptidase 4 positive fibroblasts using zinc sulfide cellulose nanofiber scaffolds to achieve scarless healing
- Repurposing DPP4-Inhibition to Improve Hair Follicle Activation and Regeneration
- 755 Repurposing of DPP4 inhibition to improve hair follicle activation and regeneration
- 973 Dipeptidyl-peptidase 4 (DPP4)-positive fibroblasts are responsible for secretion of pro-fibrotic matrix proteins in the human skin
- Negative term supplementary protection certificates granted by UK Intellectual Property Office
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Editorial for issue 3 of 2012, Journal of Evidence Based Medicine
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Debatable Topics in PCOS Patients
- Dermatological Drugs, Topical Agents, and Cosmetics
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review
- Holistic management plan for polycystic ovarian syndrome (PCOS): A systematic literature review
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome